Have a personal or library account? Click to login
Brief Communication (Original). Utilization of rabies immunoglobulin in seven urban Pakistan emergency rooms Cover

Brief Communication (Original). Utilization of rabies immunoglobulin in seven urban Pakistan emergency rooms

Open Access
|Feb 2017

Abstract

Background: Human rabies is a fatal infectious disease that is entirely preventable if correct and timely postexposure prophylaxis is given. Unfortunately, rabies immunoglobulin (RIG) administration, a life-saving biological, is often avoided by emergency room health care providers (HCPs)

Objective: To understand the practices of HCPs for administration of RIG in severe dog-bite exposures, which are common causes of emergency room visits in Pakistan.

Methods: A cross-sectional study was conducted among 103 HCPs working in seven hospitals in three cities of Pakistan.

Results: Of 103 HCPs who responded to the questionnaires, 97.1% had administered rabies vaccine and 31.1% had administered ERIG in the past three years of their practice; three quarters said they would prefer to use HRIG if available. Thirty-five percent said they would not inject wounds at all, 24.3% would only vaccinate a patient with severe dog bites, but not administer RIG. More than 55% were concerned about the cost of human and equine RIG.

Conclusion: Although there is awareness about the use of RIG, this life saving biological is grossly underused because of poor availability in clinics and emergency rooms (ERs) even though stocked by local suppliers. Hospitals and animal bite centers must make RIG available for severe exposures.

DOI: https://doi.org/10.5372/1905-7415.0702.172 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 243 - 247
Published on: Feb 4, 2017
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2017 Salahuddin Naseema, Mubashar N, Ansari B, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.